Fairvalue-Calculator Fairvalue-Calculator
EN DE

GoHealth, Inc (GOCO) Fair Value & Analysis

Financial Services · US · Market cap $8.9M

Price$0.3350
Fair Value$0.5600
Upside+67.2%
Quality80/100
Evidence: Low Range $0.4179 – $0.8358

Fair value as of: Jun 26, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

GoHealth, Inc (GOCO) currently trades at $0.3350, while our model-based Fair Value estimate is $0.5600 — implying the stock looks roughly 67.2% undervalued today. We read business quality at 80/100 (high quality), in the Financial Services sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

GoHealth, Inc. operates as a health insurance marketplace and Medicare-focused digital health company in the United States. The company offers Medicare plans, including Medicare advantage, Medicare supplement, prescription drug plans, and special needs plans. It also operates a technology platform that leverages machine-learning algorithms of insurance purchasing behavior to reimagine the process of matching a health plan for a consumer's specific needs. In addition, the company offers partner marketing services. It sells its products through internal and external agencies, as well as its platform. GoHealth, Inc. was founded in 2001 and is headquartered in Chicago, Illinois.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is GoHealth, Inc (GOCO) undervalued?
As of Jun 26, 2026, our model estimates a fair value of $0.5600 versus a price of $0.3350 — about +67% (undervalued). Model-based estimate, not financial advice.
What is the fair value of GOCO?
Our 21-model fair value for GoHealth, Inc is $0.5600 (as of Jun 26, 2026), built from audited fundamentals. The current price is $0.3350.
What is the quality score of GOCO?
GoHealth, Inc has a Quality Score of 80/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.